瑞雷治疗 RLAY
$18.60 +$1.60 (+9.41%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $18.88 +1.51%
开盘$17.14
昨收$17.00
当日区间$16.66 – $18.72
成交量3.20M
市值$4.11B
市盈率（TTM）–
股息率–
财报
财报日平均波动±4.3%近16次财报
收涨次数5 / 1631% 的概率
最佳反应+12.0%
最差反应-13.3%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±18.1% | +0.10% | 符合区间 |
| 2026/Q1 | 5 May 2026 | After Market | ±16.7% | -0.62% | 符合区间 |
| 2025/Q4 | 26 Feb 2026 | After Market | – | +12.01% | – |
| 2025/Q3 | 6 Nov 2025 | After Market | ±34.1% | -7.35% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±30.1% | -7.74% | 符合区间 |
| 2025/Q1 | 5 May 2025 | After Market | ±28.3% | -5.12% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±61.3% | -13.33% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±25.3% | -1.76% | 符合区间 |
| 2024/Q2 | 6 Aug 2024 | After Market | ±25.6% | -7.93% | 符合区间 |
| 2024/Q1 | 2 May 2024 | After Market | ±27.4% | -0.57% | 符合区间 |
| 2023/Q4 | 22 Feb 2024 | After Market | ±22.2% | -5.39% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | After Market | ±25.7% | +1.62% | 符合区间 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±11.2% | +0.09% | 符合区间 |
| 2023/Q1 | 4 May 2023 | After Market | ±21.9% | +0.45% | 符合区间 |
| 2022/Q4 | 23 Feb 2023 | After Market | ±25.0% | -2.12% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | After Market | ±20.9% | -2.15% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$350,000.00-48.3% YoY
营业利润-$90.82M-18.2% YoY
净利润-$83.71M-18.9% YoY
摊薄每股收益-$0.41+0.0% YoY
自由现金流-$54.11M+2.1% YoY
经营现金流-$54.11M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
营业利润率-2,999.4%
净利率-2,763.6%
净资产收益率-36.8%
资产收益率-33.7%
投入资本回报率-38.3%
流动比率18.27
负债/资产比率8.0%
现金及投资$910.93M
总负债$26.64M
净现金（净负债）$884.29M
暂无评论——快来第一个聊聊 RLAY。
登录后参与讨论。